POB 1483, Baltimore, MD 21203-1483, 410-243-5864
WLA Home
Asbestos Watch
British Asbestos
Newsletter
News from India
Legal Information
Publications
News Reports
Paul Safchuck's Alerts
Jim Fite's Alerts
WLA Alerts & News
World Trade Center Health
Links
 

Workplace Exposure to Asbestos:
Review and Recommendations

BIOLOGIC EFFECTS OF
EXPOSURE TO ASBESTOS
IN ANIMALS

Memorandum on Asbestos Update and Recommended Occupational Standard
I. Asbestos Nomenclature/Definitions
II. Asbestos Sampling and Analysis
III. Biologic Effects of Exposure to Asbestos in Animals
IV. Biologic Effects of Exposure to Asbestos in Humans
V. Smoking and Asbestos
VI. Exposure to Asbestiform Minerals other than Commerically Mined Asbestos
VII. Non-Occupational Exposure to Commerical Sources of Asbestos
VIII. Dose-Response Relationships
References


In Vivo

Animal studies reported since 1976, in which several types of asbestos have been utilized, further support the findings published in the NIOSH Revised Recommended Asbestos Standard. In that publication, reference was made to research which adequately demonstrated that all commercial forms and several other types of asbestos can produce mesotheliomas and primary bronchogenic neoplasms in animals.

Although mesotheliomas were most readily produced by intrapleural injections, they were also produced by inhalation exposures (Wagner et al., 1974). Since then, additional studies by Wagner et al. (1979) have shown that a commercial grade, predominantly short fiber Canadian chrysotile, which is used primarily for paint and plastic tile fillers, can induce mesotheliomas when injected intrapleurally into rats, and induce primary lung neoplasms when the animals are exposed by inhalation.

Not only is chrysotile as potent as crocidolite and other amphiboles in inducing mesotheliomas after intrapleural injections (Wagner et al., 1973), but also equally potent in inducing pulmonary neoplasms after inhalation exposures (Wagner et al., 1974). In terms of degree of response related to the quantity of dust deposited and retained in the lungs of rats, chrysotile appears to be much more fibrogenic and carcinogenic than the amphiboles (Wagner et al., 1974). The concentration of dust in the lungs of rats exposed to Canadian chrysotile was only 1.8-2.2% of the dust concentration in the lungs of animals exposed to amphiboles (after 24 months of inhalation exposures). Yet the lung tumor incidences and degrees of pulmonary fibrosis were similar in all groups. The reasons for higher incidences of lung cancer and mesotheliomas in workers exposed to amphiboles is, therefore, probably related to higher concentrations of respirable fibers during their exposures.

Research to this day has not been able to establish a fiber length below which there exists no carcinogenic potential by inhalation, the most common route of occupational exposure. This is true because of the unavailability of specifically sized fibers (Pott, 1979).

Not only were naturally occurring fibers carcinogenic, but synthetic fibers were carcinogenic as well. Pylev (1979) obtained mesotheliomas in 54% of rats injected intrapleurally with a milled synthetic hydroxy-amphibole, and primary lung neoplasms in 23% of hamsters injected intratracheally with a synthetic chrysotile. Mesotheliomas were also induced in 9/60 hamsters injected intrapleurally with glass fibers, 82% of which were greater than 20 mcm in length (Smith et al, 1979).

Further experimentation with fibers of differing diameters and lengths supports the previous observation that long, thin fibers are much more carcinogenic than short or thick fibers. Utilizing 16 preparations of fiberglass of differing fiber lengths and diameters, Stanton et al. (1977) were able to show that glass fibers with diameters less than 1.5 mcm and lengths greater than 8 mcm were carcinogenic in the pleura of rats, and that fibers shorter or wider than those were much less carcinogenic. For example, one preparation in which 60% of the fibers were less than 1.5 mcm in diameter induced pleural sarcomas in 64% of rats, whereas another preparation in which only 16% of the fibers were less than 1.5 mcm in diameter induced pleural sarcomas in only 14% of rats. Ninety-five percent of the fibers in both preparations were greater than 8 mcm in length.

Besides the corroborating evidence for the carcinogenic potential of asbestos, recent results indicate a strong co-carcinogenic effect. Kung-Vosamae and Vinkmann (1979) reported a strong synergism between nitroso-diethylamine (NDEA) administered orally and chrysotile given intratracheally. NDEA given orally alone induced lung tumors in only 2% of the hamsters, whereas NDEA administered orally plus Canadian chrysotile given intratracheally induced lung neoplasms in 40%. Chrysotile alone induced no lung tumors.

Additional research on the transport of fibers into tissues has confirmed that fibers reach the lymphatics shortly after oral administration (Masse et al., 1979). In view of the ability of intratracheally administered chrysotile to act synergistically with at least one nitrosamine, it is possible that ingested asbestos could act synergistically with orally administered nitrosamines to induce cancer in the gastrointestinal tract.


In Vitro

In vitro studies of all commercial forms of asbestos have been inconsistent when repeated or performed at different laboratories. Their correlation with in vivo studies has also been inconsistent and, thus, their value in studying the etiology of asbestos induced diseases is unclear at present.


Memorandum on Asbestos Update and Recommended Occupational Standard
I. Asbestos Nomenclature/Definitions
II. Asbestos Sampling and Analysis
III. Biologic Effects of Exposure to Asbestos in Animals
IV. Biologic Effects of Exposure to Asbestos in Humans
V. Smoking and Asbestos
VI. Exposure to Asbestiform Minerals other than Commerically Mined Asbestos
VII. Non-Occupational Exposure to Commerical Sources of Asbestos
VIII. Dose-Response Relationships
References

BACK TOC NEXT


For more information about the White Lung Association and its programs, please contact Jim Fite, jfite@whitelung.org
Page maintained by Cyndi Norman, webmaster@whitelung.org of Clarity Consulting / Last Modified: 2/5/00